Navigating Next Steps in Lymphoma Treatment

This chapter explores a complex lymphoma case where the patient has undergone several treatment regimens, including CAR T-cell therapy and bispecific antibodies. The speakers evaluate emerging treatment options and their efficacy, emphasizing the importance of real-world evidence and the management of treatment-related toxicities. They also discuss the transitional journey of bispecific therapies from clinical trials to community practices and the critical role of shared decision-making among healthcare providers.